Tyropanoate
WikiDoc Resources for Tyropanoate |
Articles |
---|
Most recent articles on Tyropanoate Most cited articles on Tyropanoate |
Media |
Powerpoint slides on Tyropanoate |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on Tyropanoate at Clinical Trials.gov Clinical Trials on Tyropanoate at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Tyropanoate
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on Tyropanoate Discussion groups on Tyropanoate Patient Handouts on Tyropanoate Directions to Hospitals Treating Tyropanoate Risk calculators and risk factors for Tyropanoate
|
Healthcare Provider Resources |
Causes & Risk Factors for Tyropanoate |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [1] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.
Tyropanoic acid and its salt sodium tyropanoate are radiopaque contrast media used in cholecystography (X-ray diagnosis of gallstones). Trade names include Bilopaque, Lumopaque, Tyropaque, and Bilopac.[1] The molecule contains three heavy iodine atoms which obstruct X-rays in the same way as the calcium in bones to produce a visible image. After injection it is rapidly excreted into the bile.[2]
References
- ↑ "PubChem CID 5611".
- ↑ PMID 7364937